EPO906 (patupilone)

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Colon CancerFallopian Tube CancerOvarian CancerPeritoneal Neoplasms

Phase 1

Dose-Escalation Study in Advanced Colon Cancer Patients

CompletedNCT00969046

Novartis PharmaceuticalsColon Cancer

Start: 2003-11-30End: 2006-11-30Updated: 2020-12-08

Phase 3

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

CompletedNCT00262990

Novartis PharmaceuticalsFallopian Tube Cancer, Ovarian Cancer, Peritoneal Neoplasms

Start: 2005-11-30Updated: 2020-12-17